Oncology & Cancer

Clinical trial targets advanced prostate cancer

Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.

Oncology & Cancer

RNA regulator of melanoma could be a new target for cancer therapy

Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise. In a study published online ...

Oncology & Cancer

Stopping hormones might help breast cancer to regress

As soon as women quit hormone therapy, their rates of new breast cancer decline, supporting the hypothesis that stopping hormones can lead to tumor regression, according to a report e-published in Cancer Epidemiology, Biomarkers, ...

page 2 from 3